[go: up one dir, main page]

NO20000976L - peptides - Google Patents

peptides

Info

Publication number
NO20000976L
NO20000976L NO20000976A NO20000976A NO20000976L NO 20000976 L NO20000976 L NO 20000976L NO 20000976 A NO20000976 A NO 20000976A NO 20000976 A NO20000976 A NO 20000976A NO 20000976 L NO20000976 L NO 20000976L
Authority
NO
Norway
Prior art keywords
peptides
cancer
synthetic peptides
treatment compositions
protein products
Prior art date
Application number
NO20000976A
Other languages
Norwegian (no)
Other versions
NO20000976D0 (en
Inventor
Gustav Gaudernack
Marianne Klemp Gjertsen
Jon Amund Eriksen
Original Assignee
Norsk Hydro As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9718110A external-priority patent/GB2328689A/en
Application filed by Norsk Hydro As filed Critical Norsk Hydro As
Priority to NO20000976A priority Critical patent/NO20000976L/en
Publication of NO20000976D0 publication Critical patent/NO20000976D0/en
Publication of NO20000976L publication Critical patent/NO20000976L/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Syntetiske peptider av onkogene proteinprodukter som fremkaller cytotoksisk T-celleimmunitet, til bruk i kreftvaksiner og sammensetninger til behandling av kreft.Synthetic peptides of oncogenic protein products that induce cytotoxic T-cell immunity, for use in cancer vaccines and cancer treatment compositions.

NO20000976A 1997-08-27 2000-02-25 peptides NO20000976L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO20000976A NO20000976L (en) 1997-08-27 2000-02-25 peptides

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9718110A GB2328689A (en) 1997-08-27 1997-08-27 Peptides based on the p21 ras proto-oncogene protein for the treatment of cancer
PCT/NO1998/000252 WO1999010382A1 (en) 1997-08-27 1998-08-26 Peptides which elicit cytotoxic t cellular immunity
NO20000976A NO20000976L (en) 1997-08-27 2000-02-25 peptides

Publications (2)

Publication Number Publication Date
NO20000976D0 NO20000976D0 (en) 2000-02-25
NO20000976L true NO20000976L (en) 2000-04-19

Family

ID=26312129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000976A NO20000976L (en) 1997-08-27 2000-02-25 peptides

Country Status (1)

Country Link
NO (1) NO20000976L (en)

Also Published As

Publication number Publication date
NO20000976D0 (en) 2000-02-25

Similar Documents

Publication Publication Date Title
NO923953D0 (en) Peptides
DK1036058T3 (en) adamantane
DE69808130D1 (en) Adamantane derivatives
TR199802423T2 (en) Concentrated antibody composition.
TR200100054T2 (en) Paroxetine methanesulfonate
ATE210988T1 (en) CYTOTOXIC AMINO SUGAR AND RELATED SUGAR DERIVATIVES OF INDOLOPYRROLOCARBAZOLES
TR200101481T2 (en) Cancer treatment composition and method using natural herbal essential oils.
SE9802937D0 (en) Novel compounds
NO983177L (en) Use of the 1-enantiomer of centroman for the preparation of a pharmaceutical composition for the treatment or prophylaxis of breast cancer
NO20000976L (en) peptides
AU1879097A (en) Fragments of cr1 and their use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application